Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Accord Healthcare Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (614)
Cancellation by sponsor (126)
Prescription medicine registration (46)
Australian Public Assessment Report (AusPAR) (3)

Date

2026 (59)
2025 (69)
2024 (32)
2023 (69)
2022 (85)
2021 (52)
2020 (48)
2019 (93)
2018 (64)
2017 (40)
2016 (70)
2015 (36)
2014 (33)
2013 (7)
2012 (16)
2011 (16)

Search

Sponsor content

789 result(s) found, displaying 731 to 740

IRINOTECAN SZ irinotecan hydrochloride trihydrate100 mg/5 mL concentrated injection vial Cancelled under s30(1)(c)

30 June 2017

Cancellation by sponsor

Requested by Accord Healthcare Pty Ltd
IRINOTECAN SZ irinotecan hydrochloride trihydrate 40 mg/2 mL concentrated injection vial Cancelled under s30(1)(c)

30 June 2017

Cancellation by sponsor

Requested by Accord Healthcare Pty Ltd
EPIRUBICIN SZ epirubicin hydrochloride 20mg/10mL concentrated injection vial Cancelled under s30(1)(c)

28 June 2017

Cancellation by sponsor

Requested by Accord Healthcare Pty Ltd
EPIRUBICIN SZ epirubicin hydrochloride 10mg/5mL concentrated injection vial Cancelled under s30(1)(c)

28 June 2017

Cancellation by sponsor

Requested by Accord Healthcare Pty Ltd
EPIRUBICIN SZ epirubicin hydrochloride 200mg/100mL concentrated injection vial Cancelled under s30(1)(c)

28 June 2017

Cancellation by sponsor

Requested by Accord Healthcare Pty Ltd
OXALIPLATIN SZ 5 mg/ml, 20 ml oxaliplatin 5 mg/ml, concentrate for solution for infusion, 20 ml Cancelled under s30(1)(c)

28 June 2017

Cancellation by sponsor

Requested by Accord Healthcare Pty Ltd
OXALIPLATIN SZ 5 mg/ml, 10 ml (oxaliplatin 5 mg/ml, concentrate for solution for infusion, 10 ml) Cancelled under s30(1)(c)

28 June 2017

Cancellation by sponsor

Requested by Accord Healthcare Pty Ltd
METHACCORD INJECTION methotrexate 50mg/2mL injection vial Cancelled under s30(1)(c)

26 June 2017

Cancellation by sponsor

Requested by Accord Healthcare Pty Ltd
OXALICCORD 5 mg/ml, 10 ml (oxaliplatin 5 mg/ml, concentrate for solution for infusion, 10 ml) Cancelled under s30(1)(c)

26 June 2017

Cancellation by sponsor

Requested by Accord Healthcare Pty Ltd
OXALICCORD 5 mg/ml, 20 ml (oxaliplatin 5 mg/ml, concentrate for solution for infusion, 20 ml) Cancelled under s30(1)(c)

26 June 2017

Cancellation by sponsor

Requested by Accord Healthcare Pty Ltd

Pages

First page
Previous page
…
Page 70
Page 71
Page 72
Page 73
Current page 74
Page 75
Page 76
Page 77
Page 78
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.